HealthQuill infectious diseases
Merck's COVID-19 pill does not stop the risk of prevention of the virus spreading to others in a household, the company stated.
Drugs Medical Pharma

Merck’s pill fails to prevent COVID-19 infection among households

Merck's COVID-19 pill does not stop the risk of prevention of the virus spreading to others in a household, the company stated.

Read More
Novavax, a US biotechnology company, announced it would deliver 1.5 million doses of its COVID-19 adjuvanted vaccine to the government.
Drugs Health Medical Pharma

Novavax to supply 1.5m COVID-19 vaccine doses to US

Novavax, a US biotechnology company, announced it would deliver 1.5 million doses of its COVID-19 adjuvanted vaccine to the government.

Read More
BioNTech SE, an immunotherapy company, will invest $43 million in a new facility in Germany to make a vital ingredient for its mRNA drugs.
Drugs Pharma

BioNTech to invest $43 million in new mRNA facility

BioNTech SE, an immunotherapy company, will invest $43 million in a new facility in Germany to make a vital ingredient for its mRNA.

Read More
A child or youth died every 4.4 seconds in 2021 and about five million children died before their fifth birthday, due to labor complications or infectious diseases, according to two separate WHO reports.
Drugs Medical Pharma

Every 4.4 seconds, a child or youth died in 2021: WHO

A child or youth died every 4.4 seconds in 2021 and about five million children died before their fifth birthday, due to labor.

Read More
Moderna, a US-based biotechnology company, hopeful of cancer vaccine by 2030
Drugs Pharma

Moderna in $35 million licensing deal with CytomX

Moderna, a US-based biotechnology company, announced a $35 million licensing deal with cancer-focused drugmaker CytomX to develop messenger RNA therapies.

Read More